RRD-251 hydrochloride

CAS No. 72214-67-6

RRD-251 hydrochloride( RRD251 hydrochloride )

Catalog No. M15762 CAS No. 72214-67-6

RRD-251 hydrochloride is a small molecule disruptor of Rb/Raf-1 interaction, potently and selectively disrupts the Rb/Raf-1 (IC50=77 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RRD-251 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    RRD-251 hydrochloride is a small molecule disruptor of Rb/Raf-1 interaction, potently and selectively disrupts the Rb/Raf-1 (IC50=77 nM).
  • Description
    RRD-251 hydrochloride is a small molecule disruptor of Rb/Raf-1 interaction, potently and selectively disrupts the Rb/Raf-1 (IC50=77 nM) but not Rb/E2F, Rb/prohibitin, Rb/cyclin E, and Rb/HDAC binding; inhibits Rb to recruit Raf-1 to proliferative promoters and inhibited E2F1-dependent transcriptional activity; inhibits anchorage-dependent and anchorage-independent growth of human cancer cells; significantly inhibits tumor growth in tumors with functional Rb in vivo.
  • In Vitro
    RRD-251 (10-50 μM; 24 hours) inhibits melanoma growth in-vitro.RRD-251 (50 μM; 2 hours) inhibits Rb-Raf-1 interaction and Rb phosphorylation in non-small cell lung cancer cells. RRD-251 induces apoptosis (50 μM; 18 hours) and cell cycle arrest (20-50 μM; 4 hours).RRD-251 alters the expression of cell cycle and apoptosis regulatory protein. Cell Proliferation Assay Cell Line:SK-MEL-28 cells , SK-MEL-5 cells, SK-MEL-2 cells Concentration:10 μM, 20 μM, 50 μM Incubation Time:24 hours Result:Inhibited melanoma growth in-vitro.Western Blot AnalysisCell Line:SK-MEL-28 cells , SK-MEL-5 cells, SK-MEL-2 cells Concentration:50 μM Incubation Time:2 hours Result:Showed the depletion of phosphorylated-Rb in RRD-251 treated cells.Apoptosis Analysis Cell Line:SK-MEL-28 cells , SK-MEL-5 cells, SK-MEL-2 cells Concentration:50 μM Incubation Time:18 hours Result:Induced apoptosis.Cell Cycle Analysis Cell Line:SK-MEL-28 cells , SK-MEL-5 cells Concentration:20 μM, 50 μM Incubation Time:4 hours Result:Resulted in a dose dependent inhibition of cell cycle progression in SK-MEL-28 and SK-MEL-5 cells, respectively.
  • In Vivo
    RRD-251 (50 mg/kg; i.p.; q.o.d; for 14 days) has anti-cancer activities in vivo on melanomas. Animal Model:8-wk-old female athymic nude mice, with SK-ME-28 xenograft Dosage:50 mg/kg Administration:Intraperitoneal administration, qod, for 14 days Result:Inhibits the growth of SK-ME-28 xenograft in nude mice.
  • Synonyms
    RRD251 hydrochloride
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    Raf
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    72214-67-6
  • Formula Weight
    271.584
  • Molecular Formula
    C8H9Cl3N2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (460.25 mM)
  • SMILES
    C1=CC(=C(C=C1Cl)Cl)CSC(=N)N.Cl
  • Chemical Name
    Carbamimidothioic acid, (2,4-dichlorophenyl)methyl ester, monohydrochloride (9CI)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kinkade R, et al. Cancer Res. 2008 May 15;68(10):3810-8. 2. Singh S, et al. Mol Cancer Ther. 2010 Dec;9(12):3330-41. 3. Trevi?o JG, et al. Mol Cancer Ther. 2013 Dec;12(12):2722-34. 4. Wallace AS, et al. Oncotarget. 2016 Jul 19;7(29):46401-46418.
molnova catalog
related products
  • CCT241161

    CCT241161 is a potent pan-RAF inhibitor with IC50 of 30, 15 and 6 nM for BRAF, V600E-BRAF and C-RAF.

  • GDC-0879

    A potent and selective B-Raf kinase inhibitor with IC50 of 0.13 nM against purified B-Raf V600E and a cellular pERK IC50 of 63 nM in the MALME-3M cell line.

  • Belvarafenib

    Belvarafenib (HM95573, GDC5573) is a novel potent, selective RAF inhibitor.